FDA approves Opill, the first OTC birth control pill in the U.S.
Roche eyes alternate mode of administration for Ocrevus in MS
Why isn't Biogen's stock soaring after this major FDA approval?
Lilly, Novo, BMS return to boost BGV's largest European biotech fund yet
*please scroll down for all the latest news*
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraudimage: 
Original Article
July 13 2023 – FDA approves Opill, the first OTC birth control pill in the U.S.
